CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in the prevalence of genetic disorders.
3.4.1.2. Growing application of gene expression in drug discovery
3.4.1.3. Rise in the demand of personalized medicine for genetic disorders
3.4.2. Restraints
3.4.2.1. High cost of gene expression instruments & reagents
3.4.2.2. Lack of skilled professionals
3.4.3. Opportunities
3.4.3.1. High growth potential in developing economies
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: GENE EXPRESSION MARKET, BY PRODUCTS
4.1. Overview
4.1.1. Market size and forecast
4.2. Consumable
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Instruments
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.3.4. Instruments Gene Expression Market by Type
CHAPTER 5: GENE EXPRESSION MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Drug Discovery
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Diagnostics
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: GENE EXPRESSION MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Pharmaceutical and Biotechnology Companies
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Academic and Research Institutes
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: GENE EXPRESSION MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Products
7.2.3. Market size and forecast, by Application
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Products
7.2.5.1.3. Market size and forecast, by Application
7.2.5.1.4. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Products
7.2.5.2.3. Market size and forecast, by Application
7.2.5.2.4. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Products
7.2.5.3.3. Market size and forecast, by Application
7.2.5.3.4. Market size and forecast, by End User
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Products
7.3.3. Market size and forecast, by Application
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Products
7.3.5.1.3. Market size and forecast, by Application
7.3.5.1.4. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Products
7.3.5.2.3. Market size and forecast, by Application
7.3.5.2.4. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Products
7.3.5.3.3. Market size and forecast, by Application
7.3.5.3.4. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Products
7.3.5.4.3. Market size and forecast, by Application
7.3.5.4.4. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Products
7.3.5.5.3. Market size and forecast, by Application
7.3.5.5.4. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Products
7.3.5.6.3. Market size and forecast, by Application
7.3.5.6.4. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Products
7.4.3. Market size and forecast, by Application
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Products
7.4.5.1.3. Market size and forecast, by Application
7.4.5.1.4. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Products
7.4.5.2.3. Market size and forecast, by Application
7.4.5.2.4. Market size and forecast, by End User
7.4.5.3. Australia
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Products
7.4.5.3.3. Market size and forecast, by Application
7.4.5.3.4. Market size and forecast, by End User
7.4.5.4. India
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Products
7.4.5.4.3. Market size and forecast, by Application
7.4.5.4.4. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Products
7.4.5.5.3. Market size and forecast, by Application
7.4.5.5.4. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Products
7.4.5.6.3. Market size and forecast, by Application
7.4.5.6.4. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Products
7.5.3. Market size and forecast, by Application
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Products
7.5.5.1.3. Market size and forecast, by Application
7.5.5.1.4. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Products
7.5.5.2.3. Market size and forecast, by Application
7.5.5.2.4. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Products
7.5.5.3.3. Market size and forecast, by Application
7.5.5.3.4. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Products
7.5.5.4.3. Market size and forecast, by Application
7.5.5.4.4. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1. Illumina Inc.
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. Agilent Technologies Inc.
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.3. Thermo Fisher Scientific Inc.
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. PerkinElmer Inc.
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Oxford Nanopore Technologies
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. Promega Corporation
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.7. PacBio
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.7.7. Key strategic moves and developments
9.8. Bio-Rad Laboratories, Inc.
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.9. F. Hoffmann-La Roche Ltd.
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.10. QIAGEN
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.10.7. Key strategic moves and developments
TABLE 01. GLOBAL GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 02. GENE EXPRESSION MARKET FOR CONSUMABLE, BY REGION, 2021-2031 ($MILLION)
TABLE 03. GENE EXPRESSION MARKET FOR INSTRUMENTS, BY REGION, 2021-2031 ($MILLION)
TABLE 04. GLOBAL INSTRUMENTS GENE EXPRESSION MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 05. GLOBAL GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 06. GENE EXPRESSION MARKET FOR DRUG DISCOVERY, BY REGION, 2021-2031 ($MILLION)
TABLE 07. GENE EXPRESSION MARKET FOR DIAGNOSTICS, BY REGION, 2021-2031 ($MILLION)
TABLE 08. GLOBAL GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 09. GENE EXPRESSION MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2031 ($MILLION)
TABLE 10. GENE EXPRESSION MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2021-2031 ($MILLION)
TABLE 11. GENE EXPRESSION MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 12. GENE EXPRESSION MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 13. NORTH AMERICA GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 14. NORTH AMERICA GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 15. NORTH AMERICA GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 16. NORTH AMERICA GENE EXPRESSION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 17. U.S. GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 18. U.S. GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 19. U.S. GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 20. CANADA GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 21. CANADA GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 22. CANADA GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 23. MEXICO GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 24. MEXICO GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 25. MEXICO GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 26. EUROPE GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 27. EUROPE GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 28. EUROPE GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 29. EUROPE GENE EXPRESSION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 30. GERMANY GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 31. GERMANY GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 32. GERMANY GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 33. FRANCE GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 34. FRANCE GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 35. FRANCE GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 36. UK GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 37. UK GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 38. UK GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 39. ITALY GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 40. ITALY GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 41. ITALY GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 42. SPAIN GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 43. SPAIN GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 44. SPAIN GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 45. REST OF EUROPE GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 46. REST OF EUROPE GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 47. REST OF EUROPE GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 48. ASIA-PACIFIC GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 49. ASIA-PACIFIC GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 50. ASIA-PACIFIC GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 51. ASIA-PACIFIC GENE EXPRESSION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 52. JAPAN GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 53. JAPAN GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 54. JAPAN GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 55. CHINA GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 56. CHINA GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 57. CHINA GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 58. AUSTRALIA GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 59. AUSTRALIA GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 60. AUSTRALIA GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 61. INDIA GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 62. INDIA GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 63. INDIA GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 64. SOUTH KOREA GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 65. SOUTH KOREA GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 66. SOUTH KOREA GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 67. REST OF ASIA-PACIFIC GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 70. LAMEA GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 71. LAMEA GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 72. LAMEA GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 73. LAMEA GENE EXPRESSION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 74. BRAZIL GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 75. BRAZIL GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 76. BRAZIL GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 77. SAUDI ARABIA GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 78. SAUDI ARABIA GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 79. SAUDI ARABIA GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 80. SOUTH AFRICA GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 81. SOUTH AFRICA GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 82. SOUTH AFRICA GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 83. REST OF LAMEA GENE EXPRESSION MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 84. REST OF LAMEA GENE EXPRESSION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 85. REST OF LAMEA GENE EXPRESSION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 86. ILLUMINA INC.: KEY EXECUTIVES
TABLE 87. ILLUMINA INC.: COMPANY SNAPSHOT
TABLE 88. ILLUMINA INC.: PRODUCT SEGMENTS
TABLE 89. ILLUMINA INC.: PRODUCT PORTFOLIO
TABLE 90. ILLUMINA INC.: KEY STRATERGIES
TABLE 91. AGILENT TECHNOLOGIES INC.: KEY EXECUTIVES
TABLE 92. AGILENT TECHNOLOGIES INC.: COMPANY SNAPSHOT
TABLE 93. AGILENT TECHNOLOGIES INC.: PRODUCT SEGMENTS
TABLE 94. AGILENT TECHNOLOGIES INC.: PRODUCT PORTFOLIO
TABLE 95. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
TABLE 96. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
TABLE 97. THERMO FISHER SCIENTIFIC INC.: PRODUCT SEGMENTS
TABLE 98. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
TABLE 99. THERMO FISHER SCIENTIFIC INC.: KEY STRATERGIES
TABLE 100. PERKINELMER INC.: KEY EXECUTIVES
TABLE 101. PERKINELMER INC.: COMPANY SNAPSHOT
TABLE 102. PERKINELMER INC.: PRODUCT SEGMENTS
TABLE 103. PERKINELMER INC.: PRODUCT PORTFOLIO
TABLE 104. PERKINELMER INC.: KEY STRATERGIES
TABLE 105. OXFORD NANOPORE TECHNOLOGIES: KEY EXECUTIVES
TABLE 106. OXFORD NANOPORE TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 107. OXFORD NANOPORE TECHNOLOGIES: PRODUCT SEGMENTS
TABLE 108. OXFORD NANOPORE TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 109. OXFORD NANOPORE TECHNOLOGIES: KEY STRATERGIES
TABLE 110. PROMEGA CORPORATION: KEY EXECUTIVES
TABLE 111. PROMEGA CORPORATION: COMPANY SNAPSHOT
TABLE 112. PROMEGA CORPORATION: PRODUCT SEGMENTS
TABLE 113. PROMEGA CORPORATION: PRODUCT PORTFOLIO
TABLE 114. PACBIO: KEY EXECUTIVES
TABLE 115. PACBIO: COMPANY SNAPSHOT
TABLE 116. PACBIO: PRODUCT SEGMENTS
TABLE 117. PACBIO: PRODUCT PORTFOLIO
TABLE 118. PACBIO: KEY STRATERGIES
TABLE 119. BIO-RAD LABORATORIES, INC.: KEY EXECUTIVES
TABLE 120. BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
TABLE 121. BIO-RAD LABORATORIES, INC.: PRODUCT SEGMENTS
TABLE 122. BIO-RAD LABORATORIES, INC.: PRODUCT PORTFOLIO
TABLE 123. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
TABLE 124. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
TABLE 125. F. HOFFMANN-LA ROCHE LTD.: PRODUCT SEGMENTS
TABLE 126. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
TABLE 127. QIAGEN: KEY EXECUTIVES
TABLE 128. QIAGEN: COMPANY SNAPSHOT
TABLE 129. QIAGEN: PRODUCT SEGMENTS
TABLE 130. QIAGEN: PRODUCT PORTFOLIO
TABLE 131. QIAGEN: KEY STRATERGIES
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
